Abstract
The Shiga family of toxins is comprised of a group of genetically and functionally related molecules whose original family member was described 100 yr ago. Up until the early 1980s this group of toxins was little more than a scientific curiosity without a clear role in disease pathogenesis. However, since the discovery of these toxins in E. coli and other Enterobacteriaceae, and their association with identifiable clinical diseases such as hemorrhagic colitis and hemolytic uremic syndrome, their pathophysiological importance has become clear. In this chapter we describe briefly the clinical relevance and mechanisms of actions of the toxins and then focus on the utility of the available methods to purify and assay the toxins.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shiga K. (1898) Ueber den Dysenteriebacillus (Bacillus dysenteriae). Zbl. Bakt. Parasit. Abt. 1 Orig. 24, 817–824.
Conradi H. (1903) Uber losliche, durch aseptische Autolyse erhaltene Giftstoffe von Ruhr-und Typhus-Bazillen. Dtsch. Med. Wochenschr. 20, 26–28.
Koster F., Levin J., Walker L., Tung K. S., Gilman R. H., Rahaman M. M., Majid M. A., Islam S., and Williams R. C., Jr. (1978) Hemolytic-uremic syndrome after shigellosis. N Engl. J. Med. 298, 927–933.
Konowalchuk J., Speirs J. I., and Stavric S. (1977) Vero response to acytotoxin of Escherichia coll. Infect. Immun. 18, 775–779.
Konowalchuk J., Dickie N., Stavric S., and Speirs J. I. (1978) Properties of an Escherichia coU cytotoxin. Infect. Immun. 20, 575–577.
Wade W. G., Thorn B. T., and Evens N. (1979) Cytotoxic enteropathogenic Escherichia coli. Lancet ii, 1235–1236.
Scotland S. M., Day N. P., and Rowe B. (1979) Production by strains of Escherichia coli of a cytotoxin (VT) affecting Vero cells. Soc. Gen. Microbiol. Quart. 6, 156–157.
Wilson M. W. and Bettelheim K. A. (1980) Cytotoxic Escherichia coli serotypes. Lancet ii, 201.
Riley L.W., Temis R.S., Helgerson S.D., McGee H.B., Wells J.G., Davis B. R., Hebert R. J., Olcott E. S., Johnson L. M., Hargrett N. T., Blake P. A., and Cohen M. L. (1983) Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl. J. Med. 308, 681–685.
Karmali M. A., Steele B. T., Petric M., and Lim C. (1983) Sporadic cases of hemolytic-ureamic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet ii, 619–620.
Acheson D. W. K. and Keusch G. T. (1996) Which Shiga toxin-producing types of E.coli are important? ASM News 62, 302–306.
Calderwood S. B., Acheson D. W. K., Keusch G. T., Barrett T. J., Griffin P. M., Swaminathan B., Kaper J. B., Levine M. M., Kaplan B. S., Karch H., O’Brien A. D., Obrig T. G., Takeda Y., Tarr P. I., and Wachsmuth I. K. (1996) Proposed new nomenclature for SLT (VT) family. ASM News 62, 118–119.
Keusch G. T., Grady G. F., Mata L. J., and Mclver J. (1972) The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae 1. J. Clin. Invest. 51, 1212–1218.
Keusch G. T., Grady G. F., Takeuchi A., and Sprinz H. (1972) The pathogenesis of Shigella diarrhea II. Enterotoxin induced acute enteritis in the rabbit ileum. J. Infect. Dis. 126, 92–95.
Moyer M.P., Dixon P.S., Rothman S.W., and Brown J.E. (1987) Cytotoxicity of Shiga toxin for primary cultures of human colonic and ileal epithelial cells. Infect. Immun. 55, 1533–1535.
Fontaine A., Arondel J., and Sansonetti P. J. (1988) Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox-mutant of Shigella dysenteriae 1. Infect Immun. 56, 3099–3109.
Keusch G. T. and Acheson D. W. K. (1997) Thrombotic thrombocytopenic pur-pura associated with Shiga toxins. Semin. HematoL 34, 106–116.
Karmali M. A., Petric M., Lim C., Fleming P. C., Arbus G. A., and Lior H. (1985) The association between idiopathic hemolytic uremic syndrome and infection by verotoxin producing Escherichia coll. J. Infect Dis. 151, 775–782.
Karmali M. A. (1989) Infection by verocytotox in-producing Escherichia coli. Microbiol. Rev. 2, 15–38.
Paik C. H., Gales K. M., and Hixon D. L. (1996) Isolation of Shiga-like toxin producing Escherichia coli (0157 and non-0157) in a community hospital. Diagn. Microbiol. Infect Dis. 26, 69–72.
Acheson D. W. K., Frankson K., and Willis D. (1998) Multicenter prevalence study of Shiga toxin-producing Escherichia coli. Annual meeting of the American Society for Microbiology, Atlanta, GA, USA, C–205.
Tschäpe H., Prager R., Steckel W., Fruth A., Tietze E., and Böhme G. (1995) Verotoxinogenic Citrobacter freundii associated with severe gastroenteritis and cases of haemolytic uraemic syndrome in a nursery school. Green butter as the infection source. Epidemiol Infect. 114, 441–450.
Paton A. W. and Paton J. C. (1996) Enterobacter cloaceae producing a Shigalike toxin It-related cytotoxin associated with a case of hemolytic-uremic syndrome. J. Clin. Microbiol. 34, 463–465.
Paton J. C. and Paton A. W. (1998) Pathogenesis and diagnosis of Shiga toxinproducing Escherichia coli infections. Clin. Microbiol. Rev. 11, 450–479.
Nataro J. P. and Kaper J. B. (1998) Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11, 142–201.
Acheson D. W. K., Moore R., DeBreuker S., Lincicome L., Jacewicz M., Skutelsky E., and Keusch G. T. (1996) Translocation of Shiga-like toxins across polarized intestinal cells in tissue culture. Infect. Immun. 64, 3294–3300.
Donowitz M., Keusch G. T., and Binder H. J. (1975) Effect of Shigella entero-toxin on electrolyte transport in rabbit ileum. Gastroenterohgy 69, 1230–1237.
Kandel G., Donohue-Rolfe A., Donowitz M., and Keusch G. T. (1989) Pathogenesis of Shigella diarrhea XVI. Selective targetting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal electrolyte transport. J. Clin. Invest. 84, 1509–1517.
Obrig T. G., Del Vecchio P. J., Brown J. E., Moran T. P., Rowland B. M., Judge T. K., and Rothman S. W. (1988) Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect. Immun. 56, 2372–2378.
Louise C. B. and Obrig T. G. (1991) Shiga toxin associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin, IL-1, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect. Immun. 59, 4173–4179.
Obrig T. G., Louise C. B., Lingwood C. A., Boyd B., Barley-Maloney L., and Daniel T. 0. (1993) Endothelial heterogeneity in Shiga toxin receptors and responses. J. Biol. Chem. 268, 15,484–15,488.
Monnens L., Savage C. 0., and Taylor C. M. (1998) Pathophysiology of hemolytic-uremic syndrome, in Escherichia coli 0757:H7and Other Shiga Toxin-Producing E. coli Strains (Kaper J. B. and O’Brien A. D., eds.), American Society for Microbiology, Washington, DC, pp. 287–292.
Hutchinson J. S., Stanimirovic D., Shapiro A., and Armstrong G. D. (1998) Shiga toxin toxicity in human cerebral endothelial cells, in Escherichia coli 0157:H7 and Other Shiga Toxin-Producing E. coli Strains (Kaper J. B. and O’Brien A. D., eds.), American Society for Microbiology, Washington, DC. pp. 323–328.
King A. J., Sundaram S., Cendoroglo M., Acheson D. W. K., and Keusch G. T. (1999) Shiga toxin induces supeioxide production in polymoiplioiiucleai cells with subsequent impairment of phagocytosis and responsiveness to phorbol esters. J. Infect. Dis. 179, 503–507.
Tesh V. L., Ramegowda B., and Samuel J. E. (1994). Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect. Immun. 62, 5085–5094.
Ramegowda B. and Tesh V. L. (1996) Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infect. Immun. 64, 1173–1180.
Van Setten P. A., Monnens L. A. H., Verstraten G., van denHeuvel L. P., and van Hinsberg V. W. (1996) Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis and induction of cytokine release. Blood88, 174–183.
Newland J. W., Strockbine N. A., Miller S. F., O’Brien A. D., and Holmes R. K. (1985) Cloning of Shiga-like toxin structural genes from a toxin converting phage of Escherichia coli. Science 230, 179–181.
O’Brien A. D., Marques L. R., Kerry C. F., Newland J. W., and Holmes R. K. (1989) Shiga-like toxin converting phage of enteiohemouhagic Escherichia coli strain 933. Microb. Pathogen. 6, 381–390.
Weinstein D.L., Jackson M. P., Perera L. P., Holmes R. K., and O’Brien A. D. (1989) In vivo formation of hybrid toxins comprising Shiga toxin and the Shigalike toxins and a role of the B subunit in localization and cytotoxic activity. Infect. Immun. 57, 3743–3750.
Smith H. W. and Linggood M. A. (1971) The transmissible nature of enterotoxin production in a human enteropathogenic strain of Escherichia coli. J. Med. Microbiol. 4, 301–305.
Calderwood S.B., Auclair F., Donohue-Rolfe A., Keusch G. T., and Mekalanos J. J. (1987) Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli. Proc. Natl. Acad. Sci. USA 84, 4364–4368.
De Grandis S., Law H., Brunton J., Gyles C., and Lingwood C. A. (1989) G lob otetrosy leer amide is recognized by the pig edema disease toxin. J. Biol. Chem. 264, 12,520–12,525.
Jackson M. P., Neill R. J., O’Brien A. D., Holmes R. K., and Newland J. W. (1987) Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli933. FEMS MicrobioL Lett. 44, 109–114.
Jackson M. P., Newland J.W., Holmes R.K., and O’Brien A. D. (1987) Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coll. Microb. Pathogen. 2, 147–153.
Kozlov Y. V., Kabishev A. A., Lukyanov E. V., and Bayev A. A. (1988) The primary structure of the operons coding for Shigella dysenteriae toxin and temperate phage H30 Shiga-like toxin. Gene 67, 213–221.
Strockbine N. A., Jackson M. P., Sung L.M., Holmes R.K., and O’Brien A.D. (1988) Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. J. Bacterial 170, 1116–1122.
Calderwood S. B. and Mekalanos J. J. (1987) Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus. J. Bacterial. 169. 4759-4764.
Mlihldorfer I., Hacker J., Keusch G. T., Acheson D. W. K., Tschape H., Kane A. V., Ritter A., Olschlager T., and Donohue-Rolfe A. (1996) Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect, hnmun. 64, 495–502.
Neely M. N. and Friedman D. I. (1998) Function and genetic analysis of regulatory regions of coliphageH-19B: location of shiga-like toxin and lysis genes suggest a role for phage functions in toxin release. MoL Microbiol 28, 1255–1267.
Newland J. W., Strockbine N. A., and Neill R. J. (1987) Cloning of genes for production of Escherichia coliShiga-like toxin II. Infect, hnmun. 55, 2675–2680.
Melton-Celsa A. R. and O’Brien A. D. (1998) Structure, biology, and relative toxicity of Shiga toxin family members for cells and animals, in Escherichia coli 0157:H7and Other ShigaToxin-ProducinglL. coli Strains (Kaper J. B. and O’Brien A. D., eds.), American Society for Microbiology, Washington, DC, pp. 121–128.
Weinstein D. L., Jackson M. P., Samuel J. E., Holmes R. K., and O’Brien A. D. (1988) Cloning and sequencing of a Shiga-like toxin type II variant from an Escherichia coli strain responsible for edema disease of swine. J. Bacteriol. 170, 4223–4230.
Donohue-Rolfe A., Keusch G. T., Edson C., Thorley-Lawson D., and Jacewicz M. (1984) Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit specific monclonal and polyclonal antibodies. J. Exp. Med. 160, 1767–1781.
Reisbig R., Olsnes S., and Eiklid K. (1981) The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60S ribosomal subunit. J. Biol. Chem. 256, 8739–8744.
Donohue-Rolfe A., Jacewicz M., and Keusch G.T. (1989) Isolation and characterization of functional Shiga toxin subunits and renatured holotoxin. Mol. MicrobioL 3, 1231–1236.
Mobassaleh M., Donohue-Rolfe A., Jacewicz M., Grand R. J., and Keusch G. T. (1988) Pathogeneis of Shigella diarrhea: evidence for a developmentally regulated glycolipid receptor for Shigella toxin involved in the fluid secretory response of rabbit small intestine. J. Infect. Dis. 157, 1023–1031.
Stein P. E., Boodhoo A., Tyrrell G. J., Brunton J. L., and Read R. J. (1992) Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli. Nature 355, 748–750.
Fraser M. E., Chernaia M. M., Kozlov Y. V., and James M. N. (1994) Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 Å resolution. Nat. Struct Biol. 1, 59–64.
Austin P. R., Jablonski P. E., Bohach G. A., Dunker A. K., and Hovde C. J. (1994) Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity. Infect. Immun. 62, 1768–1775.
Mangeney M., Richard Y., Coulard D., Tursz T., and Wiels J. (1991) CD77: an antigen of germinal center B cells entering apoptosis. Eur. J. Immunol. 21. 1131–1140.
Donohue-Rolfe A., Acheson D. W. K., Kane A. V., and Keusch G. T. (1989) Purification of Shiga toxin and Shiga-like toxin I and II by receptor analogue affinity chromatography with immobilized PI glycoprotein and the production of cross-reactive monoclonal antibodies. Infect. Immun. 57, 3888–3893.
Schmitt C. K., McKee M. L., and O’Brien A. D. (1991) Two copies of Shigalike toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H-strain E32511. Infect. Immun. 59, 1065–1073.
Lindgren S. W., Samuel J. E., Schmitt C. K., and O’Brien A. D. (1994) The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Infect. Immun. 62, 623–631.
Brown J.E., Ussery M. A., Leppla S.H., and Rothman S.W. (1998) Inhibition of protein synthesis by Shiga toxin. Activation of the toxin and inhibition of peptide elongation. FEBS. Lett. 117, 84–88.
O’Brien A. D., LaVeck G.D., Griffin D.E., and Thompson M. R. (1980) Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography. Infect. Immun. 30, 170–179.
Olsnes S., Reisbig R., and Eiklid K. (1981) Subunit structure of Shigella cyto-toxin. J. Biol. Chem. 256, 8732–8788.
Endo Y. and Tsurugi K. (1987) RNA N-glycosidase activity of ricin A-chain. Mechanism of actin of the toxic lectin ricin on eukaryotic ribosomes. J. Biol. Chem. 262, 8128–8230.
Igarashi K., Ogasswara T., Ito K., Yutsudo T., and Takada Y. (1987) Inhibition of elongation factor 1-dependent aminoacyl-tRNA binding to ribosomes by Shiga-like toxin I (VT1) from Escherichia coli O157:H7 and by Shiga toxin. FEMS Microbiol. Lett. 44, 91–94.
Endo Y., Tsurgi K., Yutsudo T., Takeda Y., Igasawara T., and Igarashi E. (1988) Site of action of A Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. Ear. J. Biochem. 171, 45–50.
Calderwood S. B., Acheson D. W. K., Goldberg M. B., Boyko S. A., and Donohue-Rolfe A. (1990) A system for production and rapid purification of large amounts of Shiga toxin/Shiga-like toxin I B subunit. Infect. Immun. 58, pp 2977–2982.
Acheson D. W. K., Calderwood S. B., Boyko S. A., Lincicome L. L., Kane A. V., Donohue-Rolfe A., and Keusch G. T. (1993) A comparison of Shiga-like toxin I B subunit expression and localization in Escherichia coli and Vibrio cholerae, using trc or iron-regulated promoter systems. Infect. Immun. 61, 1098–1104.
Ramotar K., Boyd B., Tyrrell G., Gariepe J., Lingwood C., and Brunton J. (1990) Characterization of Shiga-like toxin I B subunit purified from over-producing clones of the SLT-I B cistron. Biochemistry 272, 805–811.
Acheson D. W. K., DeBreucker S. A., Jacewicz M., Lincicome L. L., Donhue-Rolfe A., Kane A. V., and Keusch G. T. (1995) Expression and purification of Shiga-like toxin II B subunits. Infect. Immun. 63, 301–308.
Keusch G. T. and Jacewicz M. (1977) Pathogenesis of Shigella diarrhea. VII. Evidence for a cell membrane toxin receptor involving βl-4 linked N-acetyl-D-glucosamine oligomers. J. Exp. Med. 146, 535–546.
Jacewicz M., Clausen H., Nudelman E., Donohue-Rolfe A., and Keusch G. T. (1986) Pathogenesis of Shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolopid from rabbit jejunum and HeLa cells and its identification as globo-triosylceramide. J. Exp. Med. 163, 1391–1404.
Mobassaleh M., Gross S. K., McCluer R. H., Donohue-Rolfe A., and Keusch G. T. (1989) Quantitation of the rabbit intestinal glycolipid receptor for Shiga toxin. Further evidence for the developmental regulation of globotriaosy leer amide in microvillus membranes. Gastroenterology 97, 384–391.
Lindberg A. A., Brown J. E., Stromberg N., Westling-Ryd M., Schultz J. E., and Karlson K. (1987) Identification of the carbohydrate receptors for Shiga toxin produced by ShigeUa dysenteriae typel. J. Biol. Chem. 262, 1779–1785.
Kiarash A., Boyd G., and Lingwood C. A. (1994) Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. J. Biol. Chem. 269, 1139–1146.
Garred O., Dubinina E., Holm P. K., Olsnes S., van Deurs B., Kozlov J. V., and Sandvik K. (1995) Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants. Exp. Cell Res. 218, 39–49.
Sandvig K., Prydz K., Ryd M., and van Deurs B. (1991) Endocytosis and intracellular transport of the gly col ipid-b hiding ligand Shiga toxin in polarized MDCK cells. J. Cell Biol. 113, 553–562.
Sandvig K. and van Deurs B. (1996) Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin. Physiol. Rev. 76, 949–966.
Nambiar M. P. and Wu H. C. (1995) Ilimaquionone inhibits the cytotoxicities of ricin, diphtheria toxin, and other protein toxins in Vero cells. Exp. Cell Res. 219, 671–678.
Boivin A. and Mesrobeanu L. (1937) Recherches sur les toxines des bacilles dysenteriques. Sur Tidentite entre la toxine thermobile de Shiga et 1exotoxine presente dans les filtrates des cultures sur bouillon de la meme bacterie. C. Soc. Biol. 126, 323–325.
Olsnes S. and Eiklid K. (1980) Isolation and characterization of Shigella shigae cytotoxin. J. Biol. Chem. 255, 284–289.
Noda M., Yutsudo, Nakabayashi N., Hirayama T., and Takeda Y. (1987) Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin. Microb. Pathogen. 2, 339–349.
Ryd M., Alfredsson H., Blomberg L., Andersson A., and Lindberg A. A. (1989) Purification of Shiga toxin by alpha-D-galactose-(l-4)-beta-D-galactose-(l-4)-beta-D-glucose-receptor ligand-based chromatography. FEBS Lett. 258, 320–322.
Gentry M. K. and Dalrymple J. M. 1980) Quantitative microtitre cytotoxicity assay for Shigella toxin. J. Clin. Microbiol. 12, 361–366.
Keusch G. T., Donohue-Rolfe A., Jacewicz M., and Kane A. V. (1988) Shiga toxin: production and purification. Methods Enzymol. 165, 152–162.
Acheson D. W. K., Keusch G. T., Lightowers M., and Donohue-Rolfe A. (1990) Enzyme linked imunosorbent assay for Shiga toxin and Shiga-like toxin II using PI glycoprotein from hydatid cysts. J. Infect. Dis. 161, 134–137.
Ashkenazi S. and Cleary T. G. (1989) Rapid method to detect Shiga toxin and Shiga-like toxin I based on binding to globotriaosylceramide (Gb3), their natural receptor. J. Clin. Microbiol. 27, 1145–1150.
Ashkenazi S. and Cleary T. G. (1990) A method for detecting Shiga toxin and Shiga-like toxin I in pure and mixed culture. J. Med. Microbiol. 32, 255–261.
Acheson D. W. K., Jacewicz M., Kane A. V., Donohue-Rolfe A., and Keusch G. T. (1993) One step high yield purification of Shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays. Microb. Pathogen. 14, 57–66.
Hull A. E., Acheson D. W. K., Echeveria P., Donohue-Rolfe A., and Keusch G. T. (1993) Mitomycin C immunoblot colony assay for the detection of Shigalike toxin producing E.coli in fecal samples: a comparison with DNA probes. J. Clin. Microbiol. 31, 1167–1172.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Acheson, D.W.K., Kane, A.V., Keusch, G.T. (2000). Shiga Toxins. In: Holst, O. (eds) Bacterial Toxins: Methods and Protocols. Methods in Molecular Biology™, vol 145. Humana Press. https://doi.org/10.1385/1-59259-052-7:41
Download citation
DOI: https://doi.org/10.1385/1-59259-052-7:41
Publisher Name: Humana Press
Print ISBN: 978-0-89603-604-8
Online ISBN: 978-1-59259-052-0
eBook Packages: Springer Protocols